Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Cremona
Clinical trial register · Italy

Clinical Trials in Cremona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Pfizer5 Astellas Pharma Global Development, Inc.5 Gilead Sciences3 Janssen Research & Development, LLC3 Hoffmann-La Roche2
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Cremona

50 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
NCT07418164Pancreatic Cancer, Biliopancreatic Diseases, Periampullary Neoplasms
IRCCS San Raffaele
Observational
2,500
Bergamo, Brescia, Cremona, Legnano, Mantua, Milan, Monza, Pavia
2026-10-31
Recruiting
AstraZeneca
Phase 3
2,800
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples
2026-09-01
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bergamo, Bologna, Brescia, Candiolo, Cremona, Florence, Meldola, Milan
2025-05-22
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
340
Aviano, Bari, Brescia, Crema, Cremona, Florence, Genoa, Meldola
2025-03-27
Recruiting
BioNTech SE
Phase 3
621
Avellino, Aviano, Cremona, Lucca, Meldola, Monza, Naples, Peschiera del Garda
2025-02-03
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
142
Aviano (PN), Bari, Bologna, Carpi, Cremona, Cuneo, Florence, Lido di Camaiore
2025-01-24
Recruiting
BioNTech SE
Phase 2/3
1,580
Avellino, Aviano, Bologna, Candiolo, Catania, Cona, Cremona, Lucca
2025-01-07
Active, closed
mAbxience Research S.L.
Phase 3
726
Brescia, Cremona, Genova, Lecce, Meldola, Pavia, Roma, Siena
2024-12-30
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Bologna, Cremona, Florence, Milan, Modena, Padova, Piacenza, Roma
2024-12-13
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Caserta, Cremona, Naples, Rozzano, San Giovanni Rotondo, Torrette, Udine
2024-11-22
Recruiting
Pfizer
Phase 3
900
Meldola, Rome, Rozzano, Cremona, Milan, Naples, Terni, Trento
2024-10-22
Recruiting
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
NCT06804421Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit
Fondazione IRCCS San Gerardo dei Tintori
Observational
1,400
Bergamo, Bologna, Brescia, San Fermo della Battaglia, Cremona, Florence, Genova, Lecco
2024-09-28
Active, closed
Amgen
Phase 3
315
Cona, Cremona, Milan, Naples, Ravenna, Sondrio, Terni
2024-09-09
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Bologna, Brindisi, Brescia, Cuneo, Como, Cremona, Ferrara, Genova
2024-06-28
Recruiting
Summit Therapeutics
Phase 3
1,600
Ancona, Aviano, Cremona, Genova, Lucca, Mantua, Milan, Monza
2023-10-26
By invitation
Denali Therapeutics Inc.
Phase 2/3
99
Cremona, Udine
2023-09-20
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
DrugZipalertinib
Taiho Oncology, Inc.
Phase 2
220
Florence, Meldola, Cremona, Milan, Parma, Ravenna
2023-07-31
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
3,500
Aviano, Brescia, Catania, Como, Cremona, Florence, Genova, Meldola
2023-05-01
Recruiting
Consorzio Oncotech
Phase 2
118
Brescia, Candiolo, Catania, Cremona, Florence, Genova, Milan, Modena
2023-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Brescia, Cremona, Foligno, Genova, Gubbio, Lecce, Lecco, L’Aquila
2023-02-15
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Observational
326
Cremona, Florence, Milan, Abano Terme, Verona, Parma
2022-12-22
Recruiting
Neurosurgical Outcome Network
NCT06724029Aneurysms, Arteriovenous Malformations, Cavernomas, Skull Base Tumors
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
4,500
Bergamo, Brescia, Gravedona, Como, Cremona, Monza, Pavia, Sondrio
2022-12-05
Active, closed
Gilead Sciences
Phase 3
1,021
Avellino, Cremona, Genova, Milan, Naples, Pavia, Pesaro, Piacenza
2022-10-12
Recruiting
AbbVie
Phase 3
768
Misterbianco, Milan, Naples, Rome, Bari, Cremona, Messina, Perugia
2022-03-25
Active, closed
Gilead Sciences
Phase 3
603
Bergamo, Brescia, Catania, Catanzaro, Cremona, Milan, Pavia, Roma
2021-11-17
Active, closed
Spanish Breast Cancer Research Group
Phase 3
27
Alessandria, Ancona, Bolzano, Castellanza, Catania, Cremona, Florence, Genoa
2021-09-14
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Ancona, Cremona, Empoli, Florence, Milan, Perugia, Treviso
2021-08-04
Active, closed
Bristol-Myers Squibb
Phase 3
681
Cremona, Florence, Meldola, Milan, Padova, Parma, Pavia, Roma
2021-05-21
Active, closed
Pfizer
Phase 3
599
Bologna, Cremona, Meldola, San Giovanni Rotondo, Naples, Aviano, Trento, Arezzo
2021-05-12
Active, closed
Hoffmann-La Roche
Observational
800
Taranto, Reggio Calabria, Meldola, Rome, Genoa, Brescia, Cremona, Novara
2021-05-10
Recruiting
GlaxoSmithKline
Phase 2
37
Cremona
2021-04-16
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Arezzo, Candiolo, Cremona, Lecce, Meldola, Milan, Naples, Orbassano
2020-09-23
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Areezo, Candiolo, Cremona, Genova, Meldola, Milan, Pisa, Terni
2020-03-30
Active, closed
Pfizer
Phase 3
1,068
Misterobianco (CT), Cremona, Rozzano, Turin, Reggio Emilia, Arezzo, Bari, Genova
2019-12-30
Active, closed
CStone Pharmaceuticals
Phase 3
534
Feltre, Padova, Peschiera del Garda, Cremona, Pavia
2019-12-13
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Cagliari, Cremona, Naples, Padova, Pisa, Potenza, Reggio Emilia, Roma
2019-03-21
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
DrugsZolbetuximab·Nab-paclitaxel·Gemcitabine
Astellas Pharma Global Development, Inc.
Phase 2
393
Rozzano, Candiolo, Cremona, Lombardia, Milan, Toscana, Veneto
2019-03-15
Active, closed
Gilead Sciences
Phase 2
502
Arezzo, Aviano, Cremona, Genoa, Meldola, Milan, Novara, Padova
2018-08-13
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Folinic acid·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Meldola, Monza, Vicenza, Ancona, Bergamo, Cremona, Milan, Modena
2018-06-21
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
340
Alessandria, Forlì, Camposampiero, Negrar, Acquaviva delle Fonti, Biella, Brescia, Cremona
2018-06-05
Active, closed
Rna Diagnostics Inc.
Not applicable
801
Cremona
2018-04-26
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Alessandria, Arezzo, Aviano, Bergamo, Brescia, Cremona, Florence, Genova
2018-03-23
Active, closed
Pfizer
Phase 3
1,054
Bologna, Cremona, Meldola, Terni, Trento, Orbassano, Naples
2017-12-18
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Naples, Meldola, Aviano, Rome, Bergamo, Cremona, Milan, Monza
2017-09-22
Active, closed
MedSIR
Phase 2
377
Bologna, Brindisi, Cremona, Mantua, Milan, Monza, Piacenza
2017-06-26
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples
2017-05-03
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Active, closed
AstraZeneca
Phase 3
682
Bari, Bergamo, Bologna, Cremona, Florence, Lucca, Meldola, Milan
2015-10-21
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Roma, Cremona, Faenza RA, Lugo RA, Meldola (FC), Naples, Orbassano (TO), Ravenna
2014-12-17
Recruiting
Manuel Monreal
Observational
120,000
Avezzano, Belluno, Brescia, Avellino, Naples, Marcianise, Castelfranco, Cremona
2001-03
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/cremona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Cremona.

How many clinical trials are recruiting in Cremona?

21 of the 50 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 27 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Cremona), 50 studies
PhaseStudiesRecruitingShare
Phase 328856%
Observational9718%
Phase 28416%
Phase 2/3316%
Not applicable214%

Most active sponsors

Lead sponsors with the most studies (Cremona)
Lead sponsorStudiesRecruiting
Astellas Pharma Global Development, Inc.51
Pfizer51
Gilead Sciences30
Janssen Research & Development, LLC30
AstraZeneca21
BioNTech SE22
Hoffmann-La Roche20
AbbVie11
Amgen10
Arcus Biosciences, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.